The Trump administration’s confidential deals with pharmaceutical companies to lower U.S. drug prices include inducements to raise drug prices overseas and promise protection from President Donald Trump’s tariffs, according to documents shared with The Washington Post.
Secret contracts reveal undisclosed terms in Trump’s drug-pricing deals
Workers at a Pfizer research and manufacturing site in Andover, Massachusetts, in 2023. (Sophie Park/Bloomberg News/Getty Images)
